Beaulieu Joseph

Corporate Controller at Epizyme, Inc.

Sold, on record
$64k
Dollars the filings state
Form 4 sales
9
Latest Feb 7, 2022
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale Epizyme, Inc.Plan not stated
    Jan 24, 2020 2020

    Sold 330 shares at $24.63 ($8k)

    Beaulieu Joseph, Corporate Controller

    Sold 24.1% of holdings ($34k position)1,042 shares leftFiling

  2. 2 Form 4 sale Epizyme, Inc.Plan not stated
    Mar 3, 2020 +39 days

    Sold 996 shares at $22.18 ($22k)

    Beaulieu Joseph, Corporate Controller

    Sold 21.6% of holdings ($102k position)3,617 shares leftFiling

  3. 3 Form 4 sale Epizyme, Inc.Plan not stated
    Mar 25, 2020 +22 days

    Sold 212 shares at $15.28 ($3k)

    Beaulieu Joseph, Corporate Controller

    Sold 4.1% of holdings ($79k position)4,961 shares left0.6x usual sizeFiling

  4. 4 Form 4 sale Epizyme, Inc.Plan not stated
    Jun 26, 2020 +93 days

    Sold 317 shares at $16.15 ($5k)

    Beaulieu Joseph, Corporate Controller

    Sold 6.1% of holdings ($83k position)4,838 shares left1.2x usual sizeFiling

  5. 5 Form 4 sale Epizyme, Inc.Plan not stated
    Sep 2, 2020 +68 days

    Sold 1,514 shares at $12.81 ($19k)

    Beaulieu Joseph, Corporate Controller

    Sold 20.3% of holdings ($96k position)5,958 shares leftFiling

  6. 6 Form 4 sale Epizyme, Inc.Plan not stated
    Feb 4, 2021 +155 days

    Sold 227 shares at $11.21 ($3k)

    Beaulieu Joseph, Corporate Controller

    Sold 1.7% of holdings ($153k position)13,431 shares left0.7x usual sizeFiling

  7. 7 Form 4 sale Epizyme, Inc.Plan not stated
    Feb 2, 2022 +363 days

    Sold 687 shares at $1.37 ($941)

    Beaulieu Joseph, Corporate Controller

    Sold 2.3% of holdings ($40k position)28,854 shares left2.5x usual sizeFiling

  8. 8 Form 4 sale Epizyme, Inc.Plan not stated
    Feb 7, 2022 +5 days

    Sold 222 shares at $1.50 ($333)

    Beaulieu Joseph, Corporate Controller

    Sold 0.8% of holdings ($43k position)28,632 shares left0.7x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (9)

Form 144 notices and Form 4 sales by Beaulieu Joseph
Source
Feb 7, 2022Feb 9, 2022Epizyme, Inc.Corporate ControllerForm 4 sale222$3330.8%Plan not statedSEC
Feb 2, 2022Feb 4, 2022Epizyme, Inc.Corporate ControllerForm 4 sale687$9412.3%Plan not statedSEC
Feb 4, 2021Feb 5, 2021Epizyme, Inc.Corporate ControllerForm 4 sale227$3k1.7%Plan not statedSEC
Sep 2, 2020Sep 3, 2020Epizyme, Inc.Corporate ControllerForm 4 sale1,514$19k20.3%Plan not statedSEC
Jun 26, 2020Jun 30, 2020Epizyme, Inc.Corporate ControllerForm 4 sale317$5k6.1%Plan not statedSEC
Mar 25, 2020Mar 26, 2020Epizyme, Inc.Corporate ControllerForm 4 sale212$3k4.1%Plan not statedSEC
Mar 3, 2020Mar 5, 2020Epizyme, Inc.Corporate ControllerForm 4 sale996$22k21.6%Plan not statedSEC
Jan 24, 2020Jan 27, 2020Epizyme, Inc.Corporate ControllerForm 4 sale330$8k24.1%Plan not statedSEC
Jun 13, 2019Jun 14, 2019Epizyme, Inc.Corporate ControllerForm 4 sale203$2k29.0%UnusualSEC